CTRI/2018/04/013316已完成4 期
Prospective,open-label,randomized,parallel group,comparative clinical study of two topicalformulations of diclofenac diethylamine in the treatment of acute painful musculoskeletal conditions.
Armed Forces Medical College Pune0 个研究点目标入组 140 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All adult patients with acute painful musculoskeletal pain
排除标准
- •1. All patients denying consent to participate in the trial
- •2. All patients with deep abrasions and lacerations around the area of affliction
- •3. Individuals with known adverse reaction to topical Diclofenac preparations.
研究者
相似试验
招募中
不适用
Bacterial contamination of regular contact lens cases during daily wear of marketed and investigational contact lenses.ACTRN12609000067279CIBA VISIO80
暂停
3 期
A phase 3 clinical trial to study the efficacy and safety of drug fasudil in comparison with nimodipine in patients with non-traumatic subarachnoid hemorrhageCTRI/2010/091/000422Intas Pharmaceuticals Limited200
进行中（未招募）
1 期
Open label study comparing efficacy and safety of dabigatran etexilate to standard of care in paediatric patients with VTEEUCTR2013-002114-12-DEBoehringer Ingelheim Pharma GmbH & Co. KG328
进行中（未招募）
1 期
Open label study comparing efficacy and safety of dabigatran etexilate to standard of care in paediatric patients with VTEEUCTR2013-002114-12-BGBoehringer Ingelheim RCV GmbH & Co KG328
进行中（未招募）
1 期
Open label study comparing efficacy and safety of dabigatran etexilate to standard of care in paediatric patients with VTEMedDRA version: 14.1Level: LLTClassification code 10066899Term: Venous thromboembolismSystem Organ Class: 100000004866venous thromboembolismEUCTR2013-002114-12-ITBoehringer Ingelheim328